Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#156 most reported symptom for this vaccine
Ecchymosis has been reported 315 times in association with Measles, Mumps & Rubella (MMR II) vaccination in VAERS. This represents 0.4% of all 89,976 reports for this vaccine.
Among these reports, 2 mentioned death (0.63%) and 85 involved hospitalization (27.0%).
Ecchymosis is the #156 most frequently reported symptom for Measles, Mumps & Rubella (MMR II) out of 2292 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 315 reports of Ecchymosis after Measles, Mumps & Rubella (MMR II) vaccination may seem alarming, but context is critical.
The mortality rate among these reports is very low at 0.63%, suggesting most cases are non-fatal.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.